TERESA GEORGE: Open Payments
NPI 1942475918 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 60 payments from 17 companies in 2025. Trend: 2023 $1,657 · 2024 $1,954 · 2025 $1,450
Food & beverage: $1,350Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $348 |
| Janssen Biotech, Inc. | 8 | $200 |
| GENZYME CORPORATION | 7 | $182 |
| Lilly USA, LLC | 3 | $116 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $82 |
| UCB, Inc. | 2 | $71 |
| Incyte Corporation | 3 | $66 |
| Arcutis Biotherapeutics, Inc. | 3 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $54 |
| Amgen Inc. | 2 | $49 |
Products named: DUPIXENT, RINVOQ, TREMFYA, SKYRIZI, Bimzelx, EBGLYSS, ILUMYA, OPZELURA.
Industry payments across OR — which companies pay providers there.
